Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening


Idiopathic pulmonary fibrosis (IPF) is an age-related disease featuring progressive lung scarring. To elucidate the molecular basis of IPF, we performed exome sequencing of familial kindreds with pulmonary fibrosis. Gene burden analysis comparing 78 European cases and 2,816 controls implicated PARN, an exoribonuclease with no previous connection to telomere biology or disease, with five new heterozygous damaging mutations in unrelated cases and none in controls (P = 1.3 × 10−8); mutations were shared by all affected relatives (odds in favor of linkage = 4,096:1). RTEL1, an established locus for dyskeratosis congenita, harbored significantly more new damaging and missense variants at conserved residues in cases than in controls (P = 1.6 × 10−6). PARN and RTEL1 mutation carriers had shortened leukocyte telomere lengths, and we observed epigenetic inheritance of short telomeres in family members. Together, these genes explain 7% of familial pulmonary fibrosis and strengthen the link between lung fibrosis and telomere dysfunction.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Quantile-quantile plot of observed versus expected P values comparing the burden of new variants in protein-coding genes in familial pulmonary fibrosis cases and controls.
Figure 2: Segregation of heterozygous PARN mutations in familial kindreds with pulmonary fibrosis and the location of the PARN alterations in the different protein domains.
Figure 3: Segregation of heterozygous RTEL1 mutations in familial kindreds with pulmonary fibrosis and the location of the RTEL1 alterations in the different protein domains.
Figure 4: PARN and RTEL1 mutations are associated with short leukocyte telomere lengths.

Accession codes


NCBI Reference Sequence


  1. 1

    Travis, W.D. et al. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am. J. Respir. Crit. Care Med. 188, 733–748 (2013).

    Article  Google Scholar 

  2. 2

    Raghu, G. et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183, 788–824 (2011).

    Article  Google Scholar 

  3. 3

    Fingerlin, T.E. et al. Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat. Genet. 45, 613–620 (2013).

    CAS  Article  Google Scholar 

  4. 4

    Armanios, M.Y. et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N. Engl. J. Med. 356, 1317–1326 (2007).

    CAS  Article  Google Scholar 

  5. 5

    Tsakiri, K.D. et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc. Natl. Acad. Sci. USA 104, 7552–7557 (2007).

    CAS  Article  Google Scholar 

  6. 6

    Diaz de Leon, A. et al. Telomere lengths, pulmonary fibrosis and telomerase (TERT) mutations. PLoS ONE 5, e10680 (2010).

    Article  Google Scholar 

  7. 7

    Kropski, J.A. et al. A novel dyskerin (DKC1) mutation is associated with familial interstitial pneumonia. Chest 146, e1–e7 (2014).

    Article  Google Scholar 

  8. 8

    Parry, E.M. et al. Decreased dyskerin levels as a mechanism of telomere shortening in X-linked dyskeratosis congenita. J. Med. Genet. 48, 327–333 (2011).

    CAS  Article  Google Scholar 

  9. 9

    Nogee, L.M. et al. A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N. Engl. J. Med. 344, 573–579 (2001).

    CAS  Article  Google Scholar 

  10. 10

    Thomas, A.Q. et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am. J. Respir. Crit. Care Med. 165, 1322–1328 (2002).

    Article  Google Scholar 

  11. 11

    Wang, Y. et al. Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am. J. Hum. Genet. 84, 52–59 (2009).

    CAS  Article  Google Scholar 

  12. 12

    Cronkhite, J.T. et al. Telomere shortening in familial and sporadic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 178, 729–737 (2008).

    CAS  Article  Google Scholar 

  13. 13

    Marshall, R.P., Puddicombe, A., Cookson, W.O. & Laurent, G.J. Adult familial cryptogenic fibrosing alveolitis in the United Kingdom. Thorax 55, 143–146 (2000).

    CAS  Article  Google Scholar 

  14. 14

    Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S. & Goldstein, D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 9, e1003709 (2013).

    CAS  Article  Google Scholar 

  15. 15

    Ballew, B.J. et al. A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet. 9, e1003695 (2013).

    CAS  Article  Google Scholar 

  16. 16

    Deng, Z. et al. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal-Hreidarsson syndrome. Proc. Natl. Acad. Sci. USA 110, E3408–E3416 (2013).

    CAS  Article  Google Scholar 

  17. 17

    Le Guen, T. et al. Human RTEL1 deficiency causes Hoyeraal-Hreidarsson syndrome with short telomeres and genome instability. Hum. Mol. Genet. 22, 3239–3249 (2013).

    CAS  Article  Google Scholar 

  18. 18

    Walne, A.J., Vulliamy, T., Kirwan, M., Plagnol, V. & Dokal, I. Constitutional mutations in RTEL1 cause severe dyskeratosis congenita. Am. J. Hum. Genet. 92, 448–453 (2013).

    CAS  Article  Google Scholar 

  19. 19

    Ballew, B.J. et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in dyskeratosis congenita. Hum. Genet. 132, 473–480 (2013).

    CAS  Article  Google Scholar 

  20. 20

    Vannier, J.B., Pavicic-Kaltenbrunner, V., Petalcorin, M.I., Ding, H. & Boulton, S.J. RTEL1 dismantles T loops and counteracts telomeric G4-DNA to maintain telomere integrity. Cell 149, 795–806 (2012).

    CAS  Article  Google Scholar 

  21. 21

    Cogan, J.D. et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am. J. Respir. Crit. Care Med. 191, 646–655 (2015).

    CAS  Article  Google Scholar 

  22. 22

    Stuart, B.D. et al. Effect of telomere length on survival in patients with idiopathic pulmonary fibrosis: an observational cohort study with independent validation. Lancet Respir. Med. 2, 557–565 (2014).

    CAS  Article  Google Scholar 

  23. 23

    Körner, C.G. et al. The deadenylating nuclease (DAN) is involved in poly(A) tail removal during the meiotic maturation of Xenopus oocytes. EMBO J. 17, 5427–5437 (1998).

    Article  Google Scholar 

  24. 24

    Dehlin, E., Wormington, M., Korner, C.G. & Wahle, E. Cap-dependent deadenylation of mRNA. EMBO J. 19, 1079–1086 (2000).

    CAS  Article  Google Scholar 

  25. 25

    Yoda, M. et al. Poly(A)-specific ribonuclease mediates 3′-end trimming of Argonaute2-cleaved precursor microRNAs. Cell Rep. 5, 715–726 (2013).

    CAS  Article  Google Scholar 

  26. 26

    Berndt, H. et al. Maturation of mammalian H/ACA box snoRNAs: PAPD5-dependent adenylation and PARN-dependent trimming. RNA 18, 958–972 (2012).

    CAS  Article  Google Scholar 

  27. 27

    Heiss, N.S. et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nat. Genet. 19, 32–38 (1998).

    CAS  Article  Google Scholar 

  28. 28

    Vulliamy, T. et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc. Natl. Acad. Sci. USA 105, 8073–8078 (2008).

    CAS  Article  Google Scholar 

  29. 29

    Walne, A.J. et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum. Mol. Genet. 16, 1619–1629 (2007).

    CAS  Article  Google Scholar 

  30. 30

    Alder, J.K. et al. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 105, 13051–13056 (2008).

    CAS  Article  Google Scholar 

  31. 31

    Steele, M.P. et al. Clinical and pathologic features of familial interstitial pneumonia. Am. J. Respir. Crit. Care Med. 172, 1146–1152 (2005).

    Article  Google Scholar 

  32. 32

    Zaidi, S. et al. De novo mutations in histone-modifying genes in congenital heart disease. Nature 498, 220–223 (2013).

    CAS  Article  Google Scholar 

  33. 33

    Sanders, S.J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012).

    CAS  Article  Google Scholar 

  34. 34

    Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285–299 (2012).

    CAS  Article  Google Scholar 

  35. 35

    International HapMap Consortium. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851–861 (2007).

  36. 36

    Browning, B.L. & Browning, S.R. A fast, powerful method for detecting identity by descent. Am. J. Hum. Genet. 88, 173–182 (2011).

    CAS  Article  Google Scholar 

  37. 37

    Levy, D. et al. Rare de novo and transmitted copy-number variation in autistic spectrum disorders. Neuron 70, 886–897 (2011).

    CAS  Article  Google Scholar 

  38. 38

    Olson, J.M. A general conditional-logistic model for affected-relative-pair linkage studies. Am. J. Hum. Genet. 65, 1760–1769 (1999).

    CAS  Article  Google Scholar 

  39. 39

    Herbert, B.-S., Shay, J.W. & Wright, W.E. in Current Protocols in Cell Biology Vol. 18.6.1–18.6.20 (John Wiley & Sons, Inc., 2003).

Download references


We are grateful to the probands and their families for their participation, to A. Young for technical excellence, to S. Nolasco, K. Stephens and G. Wools for their help with blood sample collections, to the Yale Center for Genome Analysis for the generation of exome sequence data, and to the Yale Center for Genome Analysis and the McDermott Center Bioinformatics Core for sequence analysis. The authors acknowledge funding support from the following sources: US National Institutes of Health (NIH) National Center for Advancing Translational Sciences grant UL1TR001105; US NIH grant U54HG006504 (to the Yale Center for Mendelian Genomics); the Howard Hughes Medical Institute (R.P.L.); US NIH grant K12HD068369 (B.D.S.); and US NIH grant R01HL093096 (C.K.G.).

Author information




C.K.G., C.X. and R.P.L. conceived, designed and directed the study. J.C., S.Z., C.X., W.J., K.B. and S.M. performed genetic analyses. B.D.S., B.H., R.C., M.C. and J.W.S. performed and directed experiments. P.D., F.T., C.E.G., J.W., J.F., C.K., J.K.-T. and Y.M. contributed clinical evaluations. All authors approved the final manuscript and contributed critical revisions to its intellectual content.

Corresponding author

Correspondence to Christine Kim Garcia.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Integrated supplementary information

Supplementary Figure 1 Principal-component analysis of probands and controls.

(a) Principal-component analysis of genotypes from exome data of 99 familial pulmonary fibrosis probands demonstrating clustering with HapMap subjects of European (n = 79), Mexican (n = 19) and African-American (n = 1) ancestry. (b) European controls (n = 2,816) sequenced and analyzed by the Yale Center for Genome Analysis showing clustering with HapMap subjects of European ancestry.

Supplementary Figure 2 Reduced PARN expression of mutant mRNA and protein in EBV-transformed lymphoblastoid cell lines.

(a) PCR amplification and sequencing of genomic DNA validated the presence of the heterozygous c.529C>T (p.Gln177*) mutation in the proband of kindred F70 but not in a control DNA sample. RT-PCR from total cDNA demonstrated a lower level of the Gln177* mutant transcript than the wild-type (WT) transcript from an EBV-transformed lymphoblastoid cell line (LCL) derived from the proband of kindred 70. RT-PCR from cDNA isolated from a control LCL is also shown. Control cell lines were derived from mutation-negative individuals from these kindreds. (b) Immunoblot analysis of PARN and tubulin from LCLs derived from control subjects or from different individuals with the indicated heterozygous PARN mutation. (c) Relative PARN expression of each sample shown in b as quantified by ImageJ. *P < 0.05; n.s., not significant.

Supplementary Figure 3 Sanger sequence electropherograms of PCR products amplified from genomic DNA of probands heterozygous for mutations in PARN and RTEL1.

(a) PARN. (b) RTEL1. Wild-type cDNA sequences are listed above the tracings. Heterozygous mutations are indicated at the positions marked by the arrows. Deleted and inserted bases are boxed and result in an overlap of wild-type and mutant sequences. The predicted translated amino acid sequence of the protein (in single-letter amino acid code) and the exon-intron boundaries are indicated above the cDNA sequence.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–3 and Supplementary Tables 1–7. (PDF 516 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Stuart, B., Choi, J., Zaidi, S. et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nat Genet 47, 512–517 (2015). https://doi.org/10.1038/ng.3278

Download citation

Further reading


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing